Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Express Scripts

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019555

« Back to Dashboard

NDA 019555 describes DIPROLENE AF, which is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. Additional details are available on the DIPROLENE AF profile page.

The generic ingredient in DIPROLENE AF is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.
Summary for 019555
Applicant:Merck Sharp Dohme
Ingredient:betamethasone dipropionate
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 019555
Suppliers and Packaging for NDA: 019555
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIPROLENE AF betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019555 NDA Merck Sharp & Dohme Corp. 0085-0517 0085-0517-04 1 TUBE in 1 BOX (0085-0517-04) > 50 g in 1 TUBE
DIPROLENE AF betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019555 NDA Merck Sharp & Dohme Corp. 0085-0517 0085-0517-01 1 TUBE in 1 BOX (0085-0517-01) > 15 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM, AUGMENTED;TOPICALStrengthEQ 0.05% BASE
Approval Date:Apr 27, 1987TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.